Nandro-D 200mg/ml 10ml Vial by Kim Pharma

Usage

1. Confirm your contest date and count backward 10–14 weeks to determine the Nandro-D start point for the competition prep phase.
2. Draw 1.0 ml (200 mg) or 1.5 ml (300 mg) using an 18-gauge needle into a 2 ml or 3 ml syringe, swabbing the rubber stopper with an alcohol wipe and allowing it to dry before insertion.
3. Switch to a 23–25 gauge, 1–1.5 inch injection needle for intramuscular administration into the gluteus medius or vastus lateralis, rotating sites across each weekly split.
4. Administer doses on consistent days each week (e.g., Monday and Thursday for a twice-weekly split) to maintain an even plasma concentration profile throughout the contest prep window.
5. Mark your calendar for the planned discontinuation date — four to six weeks before stage day — and adhere strictly to avoid late-cycle water retention that compromises stage conditioning.
6. Log each injection date, volume, and injection site in a prep diary alongside weekly bodyweight and visual conditioning assessments to track the dose-response relationship across the prep arc.

Warnings

Frequently asked questions

What is the recommended Nandrolone Decanoate dose during contest prep?

During competition prep, most experienced athletes use 200–300 mg of Nandrolone Decanoate per week, calibrated to preserve lean tissue under a caloric deficit. This range is documented in nitrogen-balance studies as sufficient for positive lean-tissue retention. Higher doses used off-season are typically reduced 10–14 weeks out from a show to minimise water retention and oestrogen-related fullness.

How many weeks before a competition should Nandrolone Decanoate be discontinued?

Most competitive athletes discontinue Nandrolone Decanoate four to six weeks before the competition date. This window allows plasma concentrations to fall toward baseline, reducing subcutaneous fluid retention in the final weeks of contest conditioning. For drug-tested federations, a significantly longer clearance window — often 18 months or more — is required due to metabolite detectability timelines.

How does 200 mg/ml concentration benefit competition-phase dosing accuracy?

At 200 mg/ml, a 200 mg weekly dose measures exactly 1.0 ml — a straightforward volume that minimises measurement error with a standard 2 ml syringe. This clean ratio simplifies contest-phase programming, where precision matters more than in off-season cycles. Athletes splitting into twice-weekly administrations inject 0.5 ml per session, a manageable and consistent injection volume throughout the prep window.

Can I draw Nandro-D with an insulin syringe for contest-phase injections?

Insulin syringes are not recommended for Nandro-D due to their limited volume capacity (typically 1 ml maximum) and the viscosity of oil-based injectable solutions. A 2 ml or 3 ml syringe with an 18–21 gauge draw needle, switched to a 23–25 gauge 1–1.5 inch injection needle, is the standard approach. This combination allows accurate volume measurement and smooth intramuscular delivery.

How should the Nandro-D 10ml vial be stored after the first puncture?

After the initial draw, store the vial at room temperature (15–25°C) away from direct light and heat — refrigeration is not required and can increase oil viscosity, making drawing more difficult. Use strict aseptic technique at every draw: swab the rubber stopper with an alcohol wipe and allow it to dry before insertion. Label the vial with the opening date and discard any unused solution after 28 days. (2) angle_used

Manufacturer

Kim Pharma's packaging and container selection for injectable product lines centres on the 10 ml multi-dose vial as the primary delivery format — a deliberate choice that balances per-dose economy with clinical-grade containment standards. Vials are constructed from Type I borosilicate glass, the pharmacopoeial material of choice for parenteral oil preparations, offering chemical inertness against the sesame-oil carrier throughout shelf life. Stoppers are manufactured from bromobutyl rubber compounded for compatibility with injectable-grade oils, minimising the risk of leachable contamination over the full 10 ml content lifetime. Crimp-seal integrity is verified at the production line to confirm tamper-evidence and closure consistency before labelling. Each vial carries a batch-specific label including lot number, manufacture date, and expiry, enabling full forward and backward traceability within Kim Pharma's quality management system.